Not Yet RecruitingNot Applicable

Study on the Efficacy of Autologous Fat Grafting in Improving Hair Transplantation Outcomes for Patients With Localized Scleroderma-Related Alopecia

40 participantsStarted 2024-10-31

Plain-language summary

Investigating the efficacy and safety of autologous fat grafting combined with hair transplantation for the treatment of hair loss in patients with localized scleroderma."

Who can participate

Age range18 Years – 59 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Hair loss area exceeds one-third of the scalp.
✕. Infection of the scalp soft tissue.
✕. Suffering from psychiatric disorders, hematologic diseases, immune deficiencies, abnormalities in liver or kidney function, severe hypertension, severe diabetes, and other contraindications for surgery.
✕. Women who are pregnant or breastfeeding.
✕. BMI is less than 17, making it impossible to obtain sufficient fat.
✕. Received new vasodilator or immunosuppressive drug treatment within the past 3 months.
✕. Applied topical ointments to the surgical area within the past 2 weeks.
✕. Positive for HIV, HBV, HCV, HTLV-1 or -2, or syphilis.

What they're measuring

Hair follicle survival rate

Timeframe: From enrollment to the end of treatment at 12 months

Trial details

NCT IDNCT06646146

SponsorNanfang Hospital, Southern Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-01

Contact for this trial

Junrong Cai Cai

86+18565328278 cjr710508@qq.com

View on ClinicalTrials.gov More Fat Grafting trials